HCA peers and competitors
HCA Healthcare, Inc. · end-of-day data as of Oct 16, 2026
HCA Healthcare, Inc.
$458.84+20.3%
Hold · 27 analystsPT $468.39 +2.1%
HCA’s peers by industry and size include Bristol-Myers Squibb (BMY), Medtronic Plc (MDT) and CVS Health (CVS). Among these 12 companies HCA ranks 6th by market cap ($99.34B); its P/E of 15.4 compares with a median of 19.3 for its peers.
Peers by industry and size
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $59.75 | -1.4% | -11.3% | +9.4% | 13.2 | $122B | |
| 2 |  | $94.75 | -0.7% | -7.1% | +4.0% | 23.3 | $121B | |
| 3 |  | $92.36 | -0.2% | -16.0% | +20.9% | 24.4 | $118B | |
| 4 |  | $1,004.84 | +0.6% | 0.0% | -1.5% | 26.9 | $117B | |
| 5 |  | $294.66 | +0.5% | -23.3% | +23.9% | 30.5 | $113B | |
| 6 | | $458.84 | -2.1% | -15.4% | +2.1% | 15.4 | $99.34B | |
| 7 |  | $428.26 | 0.0% | 0.0% | +1.9% | 19.0 | $92.88B | |
| 8 |  | $218.01 | -7.8% | -7.8% | -25.0% | — | $87.04B | |
| 9 |  | $790.74 | -0.7% | -7.2% | +8.7% | 19.6 | $81.41B | |
| 10 |  | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | |
| 11 |  | $187.31 | -1.0% | -22.3% | +24.2% | 16.5 | $11.95B | |
| 12 |  | $185.10 | -1.2% | -23.9% | +11.1% | 7.6 | $10.91B |
Data as of Oct 16, 2026 close.